| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |